(RECS) Columbia Trust I - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US19761L7064 • Large Blend
RECS: U.S. Large, Mid-Cap, Blend, ETF
The Columbia Research Enhanced Core ETF (RECS) is designed to track the performance of a rules-based index that selects a subset of companies from the Russell 1000® Index. The fund invests at least 80% of its assets in the securities of this index, which is constructed to represent U.S. large- and mid-cap companies across both growth and value segments. The index typically holds between 325-400 constituents, though this number can vary as it has no fixed limit on the number of holdings. This flexible approach allows the index to adapt to market conditions while maintaining its core objective of reflecting the performance of U.S. large- and mid-cap equities.
As of the latest data, RECS has an average 20-day volume of 748,700 shares, indicating moderate trading activity. The ETF is currently priced at $32.75, slightly above its 20-day SMA of $31.58 but below its 50-day SMA of $33.12 and 200-day SMA of $33.79. This suggests that the fund is currently in a consolidation phase, with short-term momentum slightly weakening compared to its longer-term trend. The Average True Range (ATR) of 0.93 reflects relatively low volatility, making it a stable choice for investors seeking exposure to large-cap U.S. equities with reduced price fluctuations.
With assets under management (AUM) of $2.219 billion, RECS is a mid-sized ETF, offering a balance between liquidity and diversification. Its focus on a rules-based index ensures a systematic approach to portfolio construction, reducing reliance on discretionary decisions. This structure appeals to investors seeking a low-maintenance, passive investment strategy that closely tracks the performance of U.S. large- and mid-cap companies.
Additional Sources for RECS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RECS ETF Overview
Market Cap in USD | 2,219m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2019-09-25 |
RECS ETF Ratings
Growth Rating | 78.4 |
Fundamental | - |
Dividend Rating | 39.8 |
Rel. Strength | -0.56 |
Analysts | - |
Fair Price Momentum | 31.35 USD |
Fair Price DCF | - |
RECS Dividends
Dividend Yield 12m | 1.14% |
Yield on Cost 5y | 2.52% |
Annual Growth 5y | 7.12% |
Payout Consistency | 69.6% |
RECS Growth Ratios
Growth Correlation 3m | -87.9% |
Growth Correlation 12m | 54.3% |
Growth Correlation 5y | 87.7% |
CAGR 5y | 17.17% |
CAGR/Max DD 5y | 0.78 |
Sharpe Ratio 12m | 1.38 |
Alpha | -0.25 |
Beta | 0.956 |
Volatility | 25.14% |
Current Volume | 3076.1k |
Average Volume 20d | 748.7k |
As of May 02, 2025, the stock is trading at USD 33.12 with a total of 3,076,105 shares traded.
Over the past week, the price has changed by +2.44%, over one month by -0.60%, over three months by -6.07% and over the past year by +12.40%.
Yes. Based on ValueRay Analyses, Columbia Trust I (NYSE ARCA:RECS) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 78.35 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RECS as of May 2025 is 31.35. This means that RECS is currently overvalued and has a potential downside of -5.34%.
Columbia Trust I has no consensus analysts rating.
According to ValueRays Forecast Model, RECS Columbia Trust I will be worth about 36.2 in May 2026. The stock is currently trading at 33.12. This means that the stock has a potential upside of +9.36%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 36.2 | 9.4% |